Monash University

Monash University is a leader of research into cancer and blood diseases. Its internationally recognised research spans biological research including genomics and immunotherapy, therapeutics development and drug delivery, clinical trials, radiotherapy, epidemiology, health services research, psycho-oncology and palliative care. Multidisciplinary research programs are supported by state-of-the-art technology platforms across multiple schools, institutes, hospitals and partner organisations, and with engagement of clinical partners and external collaborators.  Find out more using the links below:

Technology Research Platforms

Cancer research programs at Monash are supported by state of the art research technology platforms, which include:

  • Monash Bioinformatics Platform
  • Centre for Drug Candidate Optimisation (CDCO)
  • Australian Phenomics Network (APN)
  • Centre for Human Anatomy Education 3D Printing Laboratory (CHAE3D)
  • Ramaciotti Centre for Cryo-Electron Microscopy
  • Monash Molecular Crystallisation Facility (MMCF)
  • Monash Energy Materials and Systems Institute (MEMSI)
  • Monash eResearch Centre (MeRC)
  • FishCore
  • FlowCore
  • Monash Gene Targeting Facility
  • Monash Histology Platform
  • HMSTrust Lab
  • Monash Instrumentation Facility
  • Monash Animal Research Platform (MARP)
  • Monash Antibody Technologies Facility (MATF)
  • Monash Academy for Cross and Interdisciplinary Mathematical Applications (MAXIMA)
  • Monash Biomedical Imaging (MBI)
  • Monash Centre for Electron Microscopy (MCEM)
  • MHTP Medical Genomics Facility
  • Micromon
  • Monash Micro Imaging (MMI)
  • Monash Protein Production Unit (MPPU)
  • Monash Biomedical Proteomics Facility
  • Monash Statistical Consulting Service
  • Australian Translational Medicinal Chemistry Facility
  • Monash X-Ray Platform

Find out more about Technology Research Platforms »

Monash Institute of Pharmaceutical Sciences (MIPS)

MIPS is Australia’s largest, most experienced and successful group of pharmaceutical scientists. MIPS undertake basic and translational drug discovery, drug delivery and drug development with a focus on oncology, infectious disease, pain and inflammation, neuroscience and metabolic disease. MIPS is a foundation research partner of the Cancer Therapeutics Cooperative Research Centre which is designing new cancer drugs. Find out more about Monash Institute of Pharmaceutical Sciences »

Monash Institute of Medical Engineering (MIME)

MIME fosters and coordinates translational medtech research across Monash University faculties, partner hospitals and collaborating medical research institutions. Our clinician-led research programs focus on major clinical and health system needs, and integrate expertise from across engineering, IT, science, biomedical and clinical research to develop to develop new devices, diagnostics, therapeutics, delivery systems and clinical tools. We work in close partnership with industry and hospitals to accelerate the development of new technologies through development, trials, commercialisation and adoption. MIME’s two major clinical nodes are based at the AMREP and the MHTP. Find out more about Monash Institute of Medical Engineering »

Monash Biomedicine Discovery Institute (BDI)

The Monash Biomedicine Discovery Institute is one of the largest and highest-quality biomedical research institutes in Australia. We pursue excellence in discovery research in cancer, cardiovascular disease, development and stem cells, drug discovery, immunology and infection, metabolism and obesity, neuroscience and structural biology. With more than 120 internationally-renowned research teams, we work with national and international collaborators on global health priorities. Find out more about Monash Biomedicine Discovery Institute »

School of Public Health and Preventive Medicine

Monash University’s School of Public Health and Preventative Medicine (SPHPM) is a centre of excellence in registry science. SPHPM has led the development and application of clinical quality registries nationally since the late 1990s and now hosts more than 30 national and state registries. The service is pivotal in linking clinical cancer outcomes to best practice treatment and research priorities. It can also be a tool to inform policy and allocation of health resources. SPHPM is also associated with research focused on prevention of disease including: chronic disease prevention; health promotion; increasing the evidence base of healthcare; improving quality and safety of healthcare; advancing health information technology; improving cost-effectiveness; prolonging disability free survival amongst the elderly; Improving the care of the critically ill and injured; reducing adverse health impacts of the environment and the workplace; and maintaining good research practice, including multicentre ethics and agreements. Find out more about the School of Public Health and Preventative Medicine »

Central Clinical School

The Central Clinical School (CCS) is co-located with The Alfred hospital and is a centre for clinical and biomedical research and education, offering undergraduate and postgraduate study programs. CCS is a core hub for translational research and medicine, covering a great breadth of subject areas. CCS’s research is highly collaborative, and the School is an integral part of the AMREP where world leaders partner in biomedical and clinical research. With such close links to health care providers, we can rapidly move towards health outcomes in improved patient care.

The Australian Centre for Blood Diseases (ACBD), in Monash’s Central Clinical School, aims to provide excellence in the diagnosis and treatment of blood conditions as well as play a leading role in the advancement of knowledge in this increasingly important area of Medicine. The ACBD is affiliated with The Alfred’s Haematology Department. Find out more about the Central Clinical School »

Eastern Health Clinical School

Eastern Health Clinical School (EHCS) is based at Eastern Health’s Box Hill Hospital campus, with sites also at Maroondah and Angliss Hospitals and activities across the entirety of Eastern Health. Its four Directorates are Medical Student Programs, Turning Point Alcohol and Drug Centre, Research and Higher Educations, and the Eastern Clinical Research Unit (ECRU). All clinical trials at Eastern Health are conducted through ECRU. A laboratory program in prostate cancer research falls under the auspices of the Research and Higher Education directorate, which also oversees all other aspects of research including non-trial clinical research, laboratory programs in other disciplines, and research higher degree students. The laboratory also supports research in nephrology, vascular medicine, haematology, endocrinology and gastroenterology. Find out more about Eastern Health Clinical School  »

School of Clinical Sciences at Monash Health

The School of Clinical Sciences at Monash Health is a vibrant hub of teaching and translational research with a strong collaboration between Monash University and Monash Health. SCS sits within the Faculty of Medicine, Nursing and Health Sciences, Monash University, and seeks to provide an innovative approach to research, education, teaching and clinical practice. The school provides a diverse range of specialities and prides itself on being at the forefront of medical, clinical/translational research and education.

SCS cancer researchers tackle the mysteries of cancer from several different perspectives, including research into specific cancers (e.g. lung, bowel, endometrium, brain, bladder and stomach), or investigation of the role that innate immunity, specific proteins and cancer stem cells play in the onset and development of the disease.

Importantly, our Phase I Clinical Trials Program provides researchers with the potential to translate laboratory findings into new cancer therapies for patients. Find out more about the School of Clinical Sciences  »